Transcription and protein profiling of whole blood and serum from natalizumab treated patients with developed progressive multifocal leukoencephalopathy.
Phase of Trial: Phase II
Latest Information Update: 27 May 2015
At a glance
- Drugs Natalizumab (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Pharmacodynamics
- 27 May 2015 New trial record